Insider Trading
Track Major Insider Updates On X/Twitter
MDGL Stock Insider Trading Activity
Corporate insiders are required to disclose purchases or sales of their own stock within two business days of when they occur. Using these disclosures, we collect data on MDGL stock insider trading activity, which can give hints on whether Madrigal Pharmaceuticals Inc executives are bullish or bearish on their own company.
Recent insider purchases and sales - MDGL
| Name / Title | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
|
CRAVES FRED B
|
Sale | 1587 | Mar 12, 2025 | March 14, 2025, 4:25 p.m. |
|
CRAVES FRED B
|
Sale | 800 | Mar 13, 2025 | March 14, 2025, 4:25 p.m. |
|
CRAVES FRED B
|
Sale | 800 | Mar 12, 2025 | March 14, 2025, 4:25 p.m. |
|
CRAVES FRED B
|
Sale | 2382 | Mar 12, 2025 | March 14, 2025, 4:25 p.m. |
|
CRAVES FRED B
|
Sale | 2759 | Mar 12, 2025 | March 14, 2025, 4:25 p.m. |
|
CRAVES FRED B
|
Sale | 1951 | Mar 13, 2025 | March 14, 2025, 4:25 p.m. |
|
CRAVES FRED B
|
Sale | 967 | Mar 13, 2025 | March 14, 2025, 4:25 p.m. |
|
CRAVES FRED B
|
Sale | 900 | Mar 13, 2025 | March 14, 2025, 4:25 p.m. |
|
CRAVES FRED B
|
Sale | 75 | Mar 13, 2025 | March 14, 2025, 4:25 p.m. |
|
CRAVES FRED B
|
Sale | 1000 | Mar 13, 2025 | March 14, 2025, 4:25 p.m. |
|
CRAVES FRED B
|
Sale | 400 | Mar 13, 2025 | March 14, 2025, 4:25 p.m. |
|
CRAVES FRED B
|
Sale | 200 | Mar 12, 2025 | March 14, 2025, 4:25 p.m. |
|
CRAVES FRED B
|
Sale | 1649 | Mar 13, 2025 | March 14, 2025, 4:25 p.m. |
|
Dier Mardi
SVP and CFO
|
Sale | 258 | Mar 10, 2025 | March 12, 2025, 4:32 p.m. |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
|
Sale | 400 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
|
Sale | 1412 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
|
Sale | 1043 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
|
Sale | 1077 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
|
Sale | 1657 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
|
Sale | 4701 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
|
Sale | 1146 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
|
Sale | 1777 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
|
Sale | 900 | Mar 05, 2025 | March 7, 2025, 6:40 p.m. |
|
Kelley Shannon T
General Counsel
|
Sale | 415 | Mar 03, 2025 | March 5, 2025, 5:36 p.m. |
|
Dier Mardi
SVP and CFO
|
Sale | 1187 | Mar 03, 2025 | March 5, 2025, 5:31 p.m. |
|
Dier Mardi
SVP and CFO
|
Sale | 774 | Mar 03, 2025 | March 5, 2025, 5:31 p.m. |
|
Huntsman Carole
Chief Commercial Officer
|
Sale | 563 | Mar 03, 2025 | March 5, 2025, 5:24 p.m. |
|
Huntsman Carole
Chief Commercial Officer
|
Sale | 100 | Mar 03, 2025 | March 5, 2025, 5:24 p.m. |
|
Huntsman Carole
Chief Commercial Officer
|
Sale | 100 | Mar 03, 2025 | March 5, 2025, 5:24 p.m. |
|
Huntsman Carole
Chief Commercial Officer
|
Sale | 100 | Mar 03, 2025 | March 5, 2025, 5:24 p.m. |
|
Huntsman Carole
Chief Commercial Officer
|
Sale | 200 | Mar 03, 2025 | March 5, 2025, 5:24 p.m. |
|
Huntsman Carole
Chief Commercial Officer
|
Sale | 200 | Mar 03, 2025 | March 5, 2025, 5:24 p.m. |
|
Huntsman Carole
Chief Commercial Officer
|
Sale | 300 | Mar 03, 2025 | March 5, 2025, 5:24 p.m. |
|
Huntsman Carole
Chief Commercial Officer
|
Sale | 200 | Mar 03, 2025 | March 5, 2025, 5:24 p.m. |
|
Huntsman Carole
Chief Commercial Officer
|
Sale | 71 | Mar 03, 2025 | March 5, 2025, 5:24 p.m. |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
|
Sale | 175 | Feb 28, 2025 | March 4, 2025, 10:24 p.m. |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
|
Sale | 1052 | Feb 28, 2025 | March 4, 2025, 10:24 p.m. |
|
Huntsman Carole
Chief Commercial Officer
|
Sale | 347 | Jan 24, 2025 | Jan. 27, 2025, 6:18 p.m. |
|
Sibold William John
President and CEO
|
Sale | 1584 | Jan 24, 2025 | Jan. 27, 2025, 6:12 p.m. |
|
Taub Rebecca
Pres., R&D, and CMO
|
Sale | 648 | Jan 24, 2025 | Jan. 27, 2025, 6:07 p.m. |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
|
Sale | 103 | Jan 24, 2025 | Jan. 27, 2025, 6:03 p.m. |
|
Kelley Shannon T
General Counsel
|
Sale | 277 | Jan 17, 2025 | Jan. 17, 2025, 8:10 p.m. |
|
Waltermire Robert E.
Senior VP, Chief Pharma Dev.
|
Sale | 442 | Jan 17, 2025 | Jan. 17, 2025, 8:08 p.m. |
|
Taub Rebecca
Pres., R&D, and CMO
|
Sale | 1689 | Jan 17, 2025 | Jan. 17, 2025, 8:05 p.m. |
|
CRAVES FRED B
|
Sale | 520 | Dec 03, 2024 | Dec. 5, 2024, 5:46 p.m. |
|
CRAVES FRED B
|
Sale | 3080 | Dec 03, 2024 | Dec. 5, 2024, 5:46 p.m. |
|
CRAVES FRED B
|
Sale | 1200 | Nov 25, 2024 | Nov. 27, 2024, 5:16 p.m. |
|
CRAVES FRED B
|
Sale | 2200 | Nov 25, 2024 | Nov. 27, 2024, 5:16 p.m. |
|
Huntsman Carole
Chief Commercial Officer
|
Sale | 688 | Nov 21, 2024 | Nov. 22, 2024, 5:30 p.m. |
|
Levy Richard S
|
Sale | 5000 | Nov 07, 2024 | Nov. 8, 2024, 6:07 p.m. |